On the other hand, for 12 – to 14-year-old adolescents, prevalence didn’t differ by family poverty status in any of the surveys significantly; although among non-Hispanic black adolescents, obese prevalence increased faster in non-poor vs. Poor families. Related StoriesHeart attack patients diagnosed and treated for diabetes experience improved cardiac outcomesBariatric surgery improves weight, metabolic health and standard of living in adolescents after 3 yearsBetalin launches brand-new EMP technology that could transform diabetes treatmentAdditional analyses claim that physical inactivity, sweetened beverage consumption, and skipping breakfast might contribute to these disparities.We anticipate continuing our improvement towards making ponatinib available to individuals with CML and Ph+ ALL,’ stated Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD. ‘If authorized, we think that ponatinib shall become an important new medicine for CML and Ph+ ALL patients who have become resistant or intolerant to prior tyrosine kinase inhibitor therapy.’ ARIAD anticipates acceptance and commercial release of ponatinib in the U.S. In the first one fourth of 2013. Also, the Marketing Authorization Program for ponatinib, submitted in August, has been validated by the European Medications Company , commencing their review of the application.